References
- Cancer Gene Ther. v.10 The cytotoxic effect of replication competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the Breast, ovary and colon Akbulut,H.;Zhang,L.;Tang,Y.;Deisseroth,A. https://doi.org/10.1038/sj.cgt.7700579
- Science v.274 An adenovirus mutant that replicates selectively in p53-deficient human tumor cells Bischoff,J.R.;Kim,D.H.;Williams,A.;Heise,C.;Horn,S.;Muna,M.;Ng,L.;Nye,J.A.;Sampson-Johannes,A.;Fattaey,A.;McCormick,F. https://doi.org/10.1126/science.274.5286.373
- J. Virol. v.73 p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication Harada,J.N.;Berk,A.J.
- Science v.288 Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Cavazzana-Calvo,M.;Hacein-Beym,S.;de Saint Basile,G.;Gross,F.;Yvon,E.;Nusbaum,P.;Selz,F.;Hue,C.;Certain,S.;Casanova,J.L.;Bousso,P.;Deistm,F.L.;Fischer,A. https://doi.org/10.1126/science.288.5466.669
- Cancer Gene Ther. v.6 Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells Chung,I.;Schwartz,P.E.;Crystal,R.G.;Pizzorno,G.;Leavitt,J.;Deisseroth,A.B. https://doi.org/10.1038/sj.cgt.7700017
- Gene Ther. v.8 In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase Chung-Faye,G.A.;Chen,M.J.;Green,N.K.;Burton,A.;Anderson,D.;Mautner,V.;Searle,P.F.;Kerr,D.J. https://doi.org/10.1038/sj.gt.3301557
- J. Clin. Onc. v.16 Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma Clayman,G.L.;el-Naggar,A.K.;Lippman,S.M.;Henderson,Y.C.;Frederick,M.;Merritt,J.A.;Zumstein,L.A.;Timmons,T.M.;Liu,T.J.;Ginsberg,L.;Roth,J.A.;Hong,W.K.;Bruso,P.;Goepfert,H. https://doi.org/10.1200/JCO.1998.16.6.2221
- Human Gene Ther. v.8 Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine Crystal,R.G.;Hirschowitz,E.;Lieberman,M.;Daly,J.;Kazam,E.;Henschke,C.;Yankelevitz,D.;Kemeny,N.;Silverstein,R.;Ohwada,A.;Russi,T.;Mastrangeli,A.;Sanders,A.;Cooke,J.;Harvey,B.G. https://doi.org/10.1089/hum.1997.8.8-985
- Human Gene Ther. v.7 Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer. a pilot trial Deisseroth,A.B.;Holmes,F.;Hortobagyi,G.;Champlin,R. https://doi.org/10.1089/hum.1996.7.3-401
- SUMMARY MINUTES Meeting #33 Center for Biologics Evaluation and Research, Biological Response Modifiers Advisory Committee FDA (Food and Drug Administration)
- SUMMARY MINUTES Meeting #34 Center for Biologics Evaluation and Research, Biological Response Modifiers Advisory Committee FDA (Food and Drug Administration)
- Cancer Res. v.53 The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified Freeman,S.M.;Abboud,C.N.;Whartenby,K.A.;Packman,C.H.;Koeplin,D.S.;Moolten,F.L.;Abraham,G.N
- Human Gene Ther. v.9 A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy Freytag,S.O.;Rogulski,K.R.;Paielli,D.L.;Gilbert,J.D.;Kim,J.H. https://doi.org/10.1089/hum.1998.9.9-1323
- Cancer Res. v.62 Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer Freytag,S.O.;Khil,M.;Stricker,H.;Peabody,J.;Menon,M.;DePeralta-Venturina,M.;Nafziger,D.;Pegg,J.;Paielli,D.;Brown,S.;Barton,K.;Lu,M.;Aguilar-Cordova,E.;Kim,J.H.
- Int. J. Rad. Onc. Bio. Phys. v.54 Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model Freytag,S.O.;Paielli,D.;Wing,M.;Rogulski,K.;Brown,S.;Kolozsvary,A.;Seely,J.;Barton,K.;Dragovic,A.;Kim,J.H. https://doi.org/10.1016/S0360-3016(02)03005-5
- Blood v.92 Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 millon-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation Garcia-Sanchez,F.;Pizzomo,G.;Fu,S.Q.;Nanakorn,T.;Krause,D.S.;Liang,J.;Adams,E.;Leffert,J.J.;Yin,L.H.;Cooperberg,M.R.;Hanania,E.;Wang,W.L.;Won,J.H.;Peng,X.Y.;Cote,R.;Brown,R.;Burtness,B.;Giles,R.;Crystal,R.;Deisseroth,A.B.
- Proc. Natl. Acad. Sci. USA v.93 Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colonyforming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy Hanania,E.G.Giles,R.E.;Kavanagh,J.;Fu,S.Q.;Ellerson,D.;Zu,Z.;Wang,T.;Su,Y.;Kudelka,A.;Rahman,Z.;Holmes,F.;Hortobagyi,G.;Claxton,D.;Bachier,C.;Thall,P.;Cheng,S.;Hester,J.;Ostrove,J.M.;Bird,R.E.;Chang,A.;Korbling,M.;Seong,D.;Cote,R.;Holzmayer,T.;Deisseroth,A.B. https://doi.org/10.1073/pnas.93.26.15346
- World J. Urol. v.18 Prospects for herpes-simplex-virus thymidine-kinase and cytokine gene transduction as immunomodulatory gene therapy for prostate cancer Hassan,W.;Sanford,M.A.;Woo,S.L.;Chen,S.H.;Hall,S.J. https://doi.org/10.1007/s003450050185
- Cancer Gene Ther. v.7 Synergistic effects of adenovirus expressing wild-type p53 on chemosensitivity of nonsmall cell lung cancer cells Horio,Y.;Hasegawa,Y.;Sekido,Y.;Takahashi,M.;Roth,J.A.;Shimokata,K. https://doi.org/10.1038/sj.cgt.7700148
- Cancer Res. v.53 In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase Huber,B.E.;Austin,E.A.;Good,S.S.;Knick,V.C.;Tibbels,S.;Richards,C.A.
- Proc. Natl. Acad. Sci. USA v.91 Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Huber,B.E.;Austin,E.A.;Richards,C.A.;Davis,S.T.;Good,S.S. https://doi.org/10.1073/pnas.91.17.8302
- Nature Gen. v.17 Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors Kafri,T.;Blomer,U.;Peterson,D.A.;Gage,F.H.;Verma,I.M. https://doi.org/10.1038/ng1197-314
- Cancer Res. v.62 Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients Lillo,R.;Ramirez,M.;Alvarez,A.;Santos,S.;Garcia-Castro,J.;Fernandez de Velasco,J.;Aviles,M.J.;Gomez-Pineda,A.;Diez,J.L.;Balas,A.;Vicario,J.L.;Bueren,J.A.;Garcia-Sanchez,F.
- Human Gene Ther. v.12 Clinical protocol. A Phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects MacGregor,R.R.
- J. Exp. Clin. Cancer Res. v.19 Progress towards gene therapy for cancer Marchisone,C.;Pfeffer,U.;Del Grosso,F.;Noonan,D.M.;Santi,L.;Albin,I.A.
- Science v.286 Gene therapy death prompts review of adenovirus vector Marshall,E. https://doi.org/10.1126/science.286.5448.2244
- Nat. Rev. Cancer v.1 Cancer gene therapy: fringe or cutting edge? McCormick,F. https://doi.org/10.1038/35101008
- Nature Med. v.1 Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Mineta,T.;Rabkin,S.D.;Yazaki,T.;Hunter,W.D.;Martuza,R.L. https://doi.org/10.1038/nm0995-938
- Gene Ther. v.9 Double suicide gene therapy using a replication defective herpes simplex virus vector reveals reciprocal inteference in a malignant gloma model Moriuchi,S.;Wolfe,D.;Tamura,M.;Yoshimine,T.;Miura,F.;Cohen,J.B.;Glorioso,J.C. https://doi.org/10.1038/sj.gt.3301693
- Cancer Res. v.46 Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: [aradigm for a prospective cancer control strategy Moolten,F.L.
- J. Clin. Onc. v.18 Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer Nemunaitis,J.;Swisher,S.G.;Timmons,T.;Connors,D.;Mack,M.;Doerksen,L.;Weill,D.;Wait,J.;Lawrence,D.D.;Kemp,B.L.;Fossella,F.;Glisson,B.S.;Hong,W.K.;Khuri,F.R.;Kurie,J.M.;Lee,J.J.;Lee,J.S.;Nguyen,D.M.;Nesbitt,J.C.;Perez-Soler,R.;Pisters,K.M.;Putnam,J.B.;Richli,W.R.;Shin,D.M.;Walsh,G.L. https://doi.org/10.1200/JCO.2000.18.3.609
- J. Clin. Onc. v.19 Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer Nemunaitism,J.;Khuri,F.;Ganly,I.;Arseneau,J.;Posner,M.;Vokes,E.;Kuhn,J.;McCarty,T.;Landers,S.;Blackburn,A.;Romel,L.;Randlev,B.;Kaye,S.;Kim,D. https://doi.org/10.1200/JCO.2001.19.2.289
- Expert Opinion on Biological Therapy v.2 Head and neck cancer: gene therapy approaches. Part II: genes delivered Nemunaitis,J.;O'Brien,J. https://doi.org/10.1517/14712598.2.3.311
- Clin. Cancer Res. v.7 Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo Nishizaki,M.;Meyn,R.E.;Levy,L.B.;Atkinson,E.N.;White,R.A.;Roth,J.A.;Ji,L.
- J. Clin. Onc. v.17 Genetic prodrug activation therapy for breast cancer: A phase I clinical trial of erbB-2-directed suicide gene expression Pandha,H.S.;Martin,L.A.;Rigg,A.;Hurst,H.C.;Stamp,G.W.;Sikora,K.;Lemoine,N.R. https://doi.org/10.1200/JCO.1999.17.7.2180
- Anti-cancer Drugs v.13 Efficient induction of apoptosis by ONYX-015 adenovirus in human colon cancer cell lines regardless of p53 status Petit,T.;Davidson,K.K.;Cerna,C.;Lawrence,R.A.;Von Hoff,D.D.;Heise,C.;Kirn,D.;Izbicka,E. https://doi.org/10.1097/00001813-200201000-00005
- Clinical Cancer Res. v.4 Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer Rahman,Z.;Kavanagh,J.;Champlin,R.;Giles,R.;Hanania,E.;Fu,S.;Zu,Z.;Mehra,R.;Holmes,F.;Kudelka,A.;Claxton,D.;Verschraegen,C.;Gajewski,J.;Andreeff,M.;Heimfeld,S.;Berenson,R.;Ellerson,D.;Calvert,L.;Mechetner,E.;Holzmayer,T.;Dayne,A.;Hamer,J.;Bachier,C.;Ostrove,J.;Deisseroth,A.
- Cancer Gene Ther. v.8 Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma Rainov,N.G.;Fels,C.;Droege,J.W.;Schafer,C.;Kramm,C.M.;Chou,T.C. https://doi.org/10.1038/sj.cgt.7700355
- Cancer Res. v.57 Prostate attenuated replication competent adenovirus (ARCA) CN706: a selective cytotoxic for prostate-specific antigen-positive prostate cancer cells Rodriguez,R.;Schuur,E.R.;Lim,H.Y.;Henderson,G.A.;Simons,J.W.;Henderson,D.R.
- J. Clin. Onc. v.19 Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer results of a multicenter phase II study. Schuler,M.;Herrmann,R.;De Greve,J.L.;Stewart,A.K.;Gatzemeier,U.;Stewart,D.J.;Laufman,L.;Gralla,R.;Kuball,J.;Buhl,R.;Heussel,C.P.;Kommoss,F.;Perruchoud,A.P.;Shepherd,F.A.;Fritz,M.A.;Horowitz,J.A.;Huber,C.;Rochlitz,C. https://doi.org/10.1200/JCO.2001.19.6.1750
- Cancer Res. v.56 Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging Seth,P.;Brinkmann,U.;Schwartz,G.N.;Katayose,D.;Gress,R.;Pastan,I.;Cowan,K.
- Human Gene Ther. v.10 A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group Shand,N.;Weber,F.;Mariani,L.;Bernstein,M.;Gianella-Borradori,A.;Long,Z.;Sorensen,A.G.;Barbier,N. https://doi.org/10.1089/10430349950016979
- J. National Cancer Institute v.91 Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer Swisher,S.G.;Roth,J.A.;Nemunaitis,J.;Lawrence,D.D.;Kemp,B.L.;Carrasco,C.H.;Connors,D.G.;El-Naggar,A.K.;Fossella,F.;Glisson,B.S.;Hong,W.K.;Khuri,F.R.;Kurie,J.M.;Lee,J.J.;Lee,J.S.;Mack,M.;Merritt,J.A.;Nguyen,D.M.;Nesbitt,J.C.;Perez-Soler,R.;Pisters,K.M.;Putnam,B.Jr.;Richli,W.R.;Savin,M.;Waugh,M.K. https://doi.org/10.1093/jnci/91.9.763
- Human Gene Ther. v.9 Enhancement of the herpes simplex virus thymidine kinase/ganciclovir bystander effect and its antitumor efficacy in vivo by pharmacologic manipulation of gap junctions Touraine,R.L.;Vahanian,N.;Ramsey,W.J.;Blaese,R.M. https://doi.org/10.1089/hum.1998.9.16-2385